Charles Schwab Investment Management Inc Clear Point Neuro, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 78,909 shares of CLPT stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,909
Previous 10,369
661.01%
Holding current value
$2.1 Million
Previous $123,000
665.85%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
7.83MCall Options Held
116KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$39.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$16.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$9.76 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$8.88 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$8.85 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $652M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...